Phenex Pharmaceuticals Aktiengesellschaft

ACTIVE

Waldhofer Str. 104, Heidelberg, Baden-Württemberg, Germanywww.phenex-pharma.comHolding11–50 employeesEstablished: 2002-01-01

Also known as:

phenex pharmaceuticals ag

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2002

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

25.0%

Trial Status Distribution

Active, not recruiting

25.0%

Completed

75.0%

Clinical Trials

Trials sponsored by this organization (4)

Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients

Phase 2

Completed

interventional

Oct 201312 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

Phenex Pharmaceuticals Aktiengesellschaft

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (4)

Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients

Safety Study of Px-104 in Patients with liver disease

Multiple Ascending Oral Dose Phase I Study With Px-102

Single Ascending Oral Dose Phase I Study With Px-102

Approvals

News